Finance

Lists
SABSW:NASDAQ
SAB Biotherapeutics, Inc.
$0.0011
0.00%
(0.00) 1D
Oct 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SABSW...
Mkt. cap
304.80M
Avg. vol.
60.22K
Volume
0.00
52-wk high
$0.20
52-wk low
$0.00
Beta
1.34
No. of employees
86
Mkt. cap
304.80M
Avg. vol.
60.22K
Volume
0.00
52-wk high
$0.20
52-wk low
$0.00
Beta
1.34
No. of employees
86
News stories
From web sources and news partners
About SAB Biotherapeutics, Inc.
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitesab.bio
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
8.97M
9.73M
13.40M
16.17M
Cost of revenue
8.97M
9.73M
13.40M
16.17M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.71M
6.04M
6.60M
7.20M
Operating expense
3.71M
6.04M
6.60M
7.20M
Total operating expenses
12.68M
15.77M
20.00M
23.38M
Operating income
-12.68M
-15.77M
-20.00M
-23.38M
Other non operating income
57.51M
-1.73M
144.40K
-761.00K
EBT including unusual items
45.45M
-16.86M
-18.87M
-22.49M
EBT excluding unusual items
45.45M
-16.86M
-18.87M
-22.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
45.45M
-16.86M
-18.87M
-22.49M
Net profit margin
-
-
-
-
Earnings per share
-
-0.41
-
-0.28
Interest and investment income
655.23K
700.74K
1.05M
1.71M
Interest expense
-43.29K
-63.46K
-62.74K
-62.00K
Net interest expenses
611.94K
637.28K
984.45K
1.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.91M
-15.01M
-19.25M
-22.54M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps